Bullet points of FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
- Novavax's vaccine targets the highly contagious omicron subvariant JN.1
- The vaccine provides protection against descendants of JN.1 that are currently dominant in the U.S.
- Novavax's shot is a valuable alternative for people who don't want to take mRNA shots from Pfizer and Moderna
- The FDA authorized Novavax's shot for emergency use in people ages 12 and up
cnbc.com_2 / CNBC Business by Layer3.news
npub1a8…nw4tu
2024-08-30 19:33:10
in reply to nevent1q…ejlw
Author Public Key
npub1a824tlx9pzc807ddhyy0h9mhqkfjj9j360z2a9kcmxsy6gcjhfaqxnw4tuPublished at
2024-08-30 19:33:10Event JSON
{
"id": "8e20340c1920d2ca38e9f217d975152dcc44f1f130971b161bc3ea2449da14ed",
"pubkey": "e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a",
"created_at": 1725046390,
"kind": 1,
"tags": [
[
"subject",
"Bullet points of FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout"
],
[
"p",
"e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a"
],
[
"e",
"cab24dec881d0cb561c5659fea5073caeb082670c3bd580d2b0412fc1beedae8",
"wss://articles.layer3.news",
"root"
]
],
"content": "Bullet points of FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout\n- Novavax's vaccine targets the highly contagious omicron subvariant JN.1\n- The vaccine provides protection against descendants of JN.1 that are currently dominant in the U.S.\n- Novavax's shot is a valuable alternative for people who don't want to take mRNA shots from Pfizer and Moderna\n- The FDA authorized Novavax's shot for emergency use in people ages 12 and up\n",
"sig": "dfdf2c6283cd339f93cf1a54cfa6ce3a6a6a741482d8d287859fae1bbf96aac936750244ad0ecfbac2e3a7d9e1307f1a2555a6d6121d4d15f40558d0600fc5c6"
}